Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Degenerative Joint Disease clinical trials
1 of 5 indexed Degenerative Joint Disease trials are currently recruiting.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 1 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Degenerative Joint Disease: 5 US clinical trials tracked, 1 recruiting.
Degenerative Joint Disease is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Smith & Nephew, running 2 of these trials.
Enrollment posture brief
Registry condition degenerative-joint-disease
OPEN 1 | RECR 20% | LATE 0 | EARLY 0 | RANK #3391 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (20% recruiting · 10 trials)
Degenerative Joint Disease lists 1 open slots (20% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Degenerative Joint Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Degenerative Joint Disease is recruiting below its size-band peers.
1 of 5 indexed trials (20%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Degenerative Joint Disease research.
Smith & Nephew accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.
-
Typical Degenerative Joint Disease enrolment sits around 189 participants.
Median target enrolment is 189 among the 5 trials that report a genuine target (sentinel values excluded). 1 of those (20%) plan for fewer than 100 participants.
-
Degenerative Joint Disease research leans observational.
2 interventional and 3 observational studies make up this index (40% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Safety and Effectiveness of the HIT Reverse HRS
Hip Innovation Technology
NCT05357378
A Multi-Centre Study in Patients Undergoing Total Hip Arthroplasty With the Smith+Nephew CATALYSTEM™ Primary Hip System
Smith & Nephew
NCT06564636
MRI of the TMJ in Patients With DJD
University of Minnesota
NCT07008690
Postoperative Hip Precautions After Total Hip Arthroplasty Via the Posterior Approach: A Prospective Randomized Trial
Rush University Medical Center
NCT02686528
R3 Delta Ceramic Acetabular System PAS U.S.
Smith & Nephew
NCT03056534
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Degenerative Joint Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Degenerative Joint Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Degenerative Joint Disease page
5 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Degenerative Joint Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Smith & Nephew sponsors the most Degenerative Joint Disease trials on record, review their full trial history before evaluating a specific study. See Smith & Nephew's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Degenerative Joint Disease condition card totals 5 registered trials; most-linked intervention No Hip Precautions; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.